Skip to content
Who we are
About us
Team
Board
Partnerships
Technology platform
Our technology
Manufacturing
Scientific publications and patents
Pipeline
Pipeline Overview
CEB-01
Clinical Trial CEB-01-RLS01-CT
Clinical Trial CEB-01-RLPC01-CT
Clinical Trial CEB-01-RLP01-CT
Investors
Invest in us
CEB-Shareholders Cebiotex
Shareholders Cebfunding
News
Contact
Who we are
About us
Team
Board
Partnerships
Technology platform
Our technology
Manufacturing
Scientific publications and patents
Pipeline
Pipeline Overview
CEB-01
Clinical Trial CEB-01-RLS01-CT
Clinical Trial CEB-01-RLPC01-CT
Clinical Trial CEB-01-RLP01-CT
Investors
Invest in us
CEB-Shareholders Cebiotex
Shareholders Cebfunding
News
Contact
Who we are
About us
Team
Board
Partnerships
Technology platform
Our technology
Manufacturing
Scientific publications and patents
Pipeline
Pipeline Overview
CEB-01
Clinical Trial CEB-01-RLS01-CT
Clinical Trial CEB-01-RLPC01-CT
Clinical Trial CEB-01-RLP01-CT
Investors
Invest in us
CEB-Shareholders Cebiotex
Shareholders Cebfunding
News
Contact
05/26/2023
Published paper Biomaterials Dec 2015
You might also be interested in
Cebiotex obtains EMA ODD for CEB-01 in Pancreatic Cancer
Cebiotex is proud to announce that CEB-01, our lead product
Read more
Semáforo verde en La Vanguardia (Spanish)
Read more